Clinical Trials Logo

Ganglion Cysts clinical trials

View clinical trials related to Ganglion Cysts.

Filter by:

NCT ID: NCT04800666 Completed - Clinical trials for Peripheral Facial Palsy

Effect of Stellate Ganglion Block Combined With Facial Nerve Block on the Treatment of Idiopathic Facial Paralysis

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Peripheral facial palsy is caused by damage to the facial nerve at any site of the peripheral branches after the facial nucleus.Stellate ganglion block is performed to treat peripheral facial palsy because it increases blood flow and promotes nerve regeneration.Facial Nerve Block worked with elimination of local inflammation of nerve and oppression. Facial nerve block is a treatment that inject drugs into the damaged nerve around to eliminate local inflammation and compression of the nerve.

NCT ID: NCT04800653 Completed - Clinical trials for Stellate Ganglion Block

The Effect of Stellate Ganglion Block on Postoperative Sleep Disturbance and Cognitive Function in Elderly Surgical Patients

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Postoperative delirium is an acute state of confusion, which is characterized by changes in attention and cognitive functions and fluctuations in consciousness; postoperative cognitive dysfunction is a common central nervous system complication in elderly patients after surgery, often manifested as memory, Obstacles in abstract thinking and orientation are accompanied by a decline in social activity ability. Postoperative delirium and cognitive dysfunction can prolong hospital stay, increase medical expenses, affect postoperative functional recovery, and even increase postoperative mortality. Sleep disorders are a group of diseases that affect the ability to sleep well regularly and cause severe impairment of social and occupational functions. Stellate ganglion block is a selective sympathetic ganglion block, in which a local anesthetic is injected into the loose connective tissue of the neck including the stellate ganglion. There are complex connections between stellate ganglia and multiple brain regions in the brain, which can improve postoperative delirium, cognitive function and sleep disturbance to a certain extent, and have certain guiding significance for postoperative rehabilitation of elderly patients.

NCT ID: NCT04793490 Completed - Clinical trials for Post-Dural Puncture Headache

Sphenopalatine Ganglion Block for Management of Post- Dural Puncture Headache in Obstetric Patients

Start date: March 15, 2021
Phase: N/A
Study type: Interventional

The purpose of this trial is to study the efficacy and efficiency of sphenopalatine ganglion block for management of post dural puncture headache in obstetric patients

NCT ID: NCT04727229 Completed - Clinical trials for Major Depressive Disorder

Stellate Ganglion Block for Major Depressive Disorder.

Start date: September 23, 2021
Phase: Phase 4
Study type: Interventional

This is a feasibility study, to investigate a new treatment option for major depressive disorders by performing a Stellate Ganglion Block (SGB). A SGB is an injection of local anesthetic into the sympathetic nervous system (peripheral nervous system) located in the lower part of the neck, to relieve pain in the head, neck, upper arm, and upper chest.

NCT ID: NCT04479176 Completed - Clinical trials for Sphenopalatine Ganglion Block

Comparison of Two Methods of Transnasal Sphenopalatine Ganglion Block

Start date: March 10, 2021
Phase:
Study type: Observational

The transnasal sphenopalatine ganglion block(SPGB) is administered to patients with facial or head and neck pain. In the transnasal approach, the drip and topical methods are frequently used. We compared facial temperatures and VAS after transnasal SPGB.

NCT ID: NCT04445337 Completed - ARDS Clinical Trials

Stellate Ganglion Blockade in COVID-19 Positive Patients

Start date: November 15, 2020
Phase: N/A
Study type: Interventional

This study will establish the safety and efficacy of using stellate ganglion blocks in patients with ARDS due to COVID-19 disease.

NCT ID: NCT04402840 Completed - COVID-19 Clinical Trials

Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS)

Start date: April 24, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to understand if it is safe and useful to perform SGB (Stellate Ganglion Block) in patients who have severe lung injury Acute Respiratory Distress Syndrome (ARDS) due to COVID-19 infection.

NCT ID: NCT04208477 Completed - Clinical trials for Traumatic Brain Injury

"The Effect of Stellate Ganglion Block in Severe Brain Injury"

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

Blood flow through the brain is reduced after brain damage. Secondary brain ischemia caused by hypoxia and hypotension, further increase the susceptibility of the ischemically compromised brain to secondary impairment during this period. In order to determine whether and to what extent blockage of the stellate ganglion (BSG) affects the blood flow to the injured brain, the investigators will measure the variables of brain blood flow before and after BSG using computed tomography angiography (CTA), trans-cranial Doppler ultrasound (TCD), intracranial pressure (ICP) and perfusion computed tomography (PCT) of the brain. At the same time, the investigators would like to evaluate whether and to what extent BSG affects the aseptic inflammatory brain injury response and the biochemical indicators of brain damage in patients with moderate and severe brain injury.

NCT ID: NCT04121338 Completed - Dysautonomia Clinical Trials

Temporary Celiac Ganglion Block as a Test Before Celiac Ganglion Resection for Dysautonomia-Related Bowel Dysmotility

Start date: December 9, 2019
Phase: Phase 1
Study type: Interventional

Dysautonomia is malfunction of the autonomic nervous system. It usually results from overactivity of the sympathetic portion and over-secretion of acetylcholine. Symptoms depend on the organ involved by this sympathetic overstimulation. Involvement of the gastrointestinal system results in chronic dysmotility, nausea, vomiting, food intolerance, weight loss and need for feeding tube placement and/or parenteral feeding. Autonomic celiac ganglia resection has been shown to alleviate symptoms as it interrupts the sympathetic stimulation to the gastrointestinal (GI) system, however there is no pre surgery test to confirm the diagnosis. The investigators' objective is to temporarily block the celiac ganglion with a long acting anesthetic (liposomal bupivacaine). If symptoms abate the diagnosis is confirmed and patient will proceed to surgery.

NCT ID: NCT04020393 Completed - Pain, Postoperative Clinical Trials

The Effect of Sphenopalatine Ganglion Block in Patients Undergoing Septorhinoplasty

Start date: January 10, 2019
Phase:
Study type: Observational

The investigators reviewed retrospectively the patients that had received septorhinoplasty(SRP). 42 patients were included in the study. Demographic, clinical, surgical, and follow-up data were collected from clinical case notes. The patients that had received sphenopalatine ganglion block(SPGB) before the surgery included in the Block group (n:20) and the patients that had not received SPBG before the surgery included in the Control group (n:22). The postoperative pain(POP) scores, the amount of postoperative rescue analgesics that was used, and the postoperative nausea and vomiting(PONV) scores in the first 24 hours and, mean arterial pressure (MAP), the dose of Remifentanil that was used during the operation were compared between the groups.